Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis - PubMed (original) (raw)
Randomized Controlled Trial
. 2015 Dec;262(12):2713-21.
doi: 10.1007/s00415-015-7902-5. Epub 2015 Oct 1.
Affiliations
- PMID: 26429571
- DOI: 10.1007/s00415-015-7902-5
Randomized Controlled Trial
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis
Egil Røsjø et al. J Neurol. 2015 Dec.
Abstract
Observational studies have suggested that vitamin D may reduce inflammation in relapsing-remitting multiple sclerosis (RRMS), but this has not been clearly confirmed in randomized controlled trials. To further explore the possible anti-inflammatory effects of vitamin D in RRMS, we examined the effect of high-dose oral vitamin D3 on eleven markers of systemic inflammation in 68 RRMS patients enrolled in a double-blinded randomized placebo-controlled trial of vitamin D3 supplementation (20,000 IU/week) (NCT00785473). Serum inflammation markers and 25-hydroxyvitamin D (25(OH)D) were measured at baseline and week 96, and no restrictions were set on additional standard immunomodulatory treatment for RRMS. The mean 25(OH)D level rose from 56 ± 29 to 123 ± 34 nmol/L among patients receiving vitamin D3 supplementation, whereas only a minor increase from 57 ± 22 to 63 ± 24 nmol/L was seen in the placebo group. However, no significant differences appeared between the vitamin D group and the placebo group for any of the inflammation markers. Patients on immunomodulatory therapy had significantly higher levels of interleukin-1 receptor antagonist and chemokine (C-X-C motif) ligand 16 than patients without immunomodulatory treatment, but there were no clear synergistic effects between immunomodulatory therapy and vitamin D3 supplementation on any of the inflammation markers. The rise in 25(OH)D levels after vitamin D3 supplementation was unaffected by immunomodulatory treatment. We conclude that in this study of RRMS patients, high-dose oral vitamin D3 supplementation prominently increased serum 25(OH)D levels without affecting markers of systemic inflammation, while a more anti-inflammatory phenotype was found among patients on immunomodulatory treatment.
Keywords: Multiple sclerosis; Systemic inflammation; Vitamin D.
Similar articles
- Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis.
Smolders J, Mimpen M, Oechtering J, Damoiseaux J, van den Ouweland J, Hupperts R, Kuhle J. Smolders J, et al. Acta Neurol Scand. 2020 Jan;141(1):77-80. doi: 10.1111/ane.13185. Epub 2019 Nov 26. Acta Neurol Scand. 2020. PMID: 31657006 Clinical Trial. - Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.
Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T. Røsjø E, et al. Mult Scler. 2017 Mar;23(3):395-402. doi: 10.1177/1352458516654310. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 27325604 - High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.
Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT. Holmøy T, et al. BMC Neurol. 2017 Apr 4;17(1):67. doi: 10.1186/s12883-017-0851-0. BMC Neurol. 2017. PMID: 28376767 Free PMC article. Clinical Trial. - A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Muris AH, Rolf L, Broen K, Hupperts R, Damoiseaux J, Smolders J. Muris AH, et al. J Steroid Biochem Mol Biol. 2016 Nov;164:254-257. doi: 10.1016/j.jsbmb.2015.11.009. Epub 2015 Nov 17. J Steroid Biochem Mol Biol. 2016. PMID: 26598277 Review. - Serum 25(OH)D response to vitamin D3 supplementation: a meta-regression analysis.
Shab-Bidar S, Bours S, Geusens PP, Kessels AG, van den Bergh JP. Shab-Bidar S, et al. Nutrition. 2014 Sep;30(9):975-85. doi: 10.1016/j.nut.2013.12.020. Epub 2014 Jan 10. Nutrition. 2014. PMID: 24993750 Review.
Cited by
- The Effectiveness of Vitamin D Intake in Improving Symptoms and Relapses of Multiple Sclerosis: A Systematic Review.
Gill A, Orji C, Reghefaoui M, Peresuodei TS, Thota P, Saavedra Palacios MS, Arcia Franchini AP. Gill A, et al. Cureus. 2024 Sep 3;16(9):e68565. doi: 10.7759/cureus.68565. eCollection 2024 Sep. Cureus. 2024. PMID: 39364460 Free PMC article. Review. - Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers.
Lis M, Niedziela N, Adamczyk-Zostawa J, Zalejska-Fiolka J, Błachut M, Szczygieł J, Świętek A, Adamczyk-Sowa M. Lis M, et al. Int J Mol Sci. 2024 Jul 11;25(14):7592. doi: 10.3390/ijms25147592. Int J Mol Sci. 2024. PMID: 39062835 Free PMC article. - Can Vitamin D Supplementation Improve Inflammation in Relapsing-Remitting Multiple Sclerosis Patients?
Lis M, Niedziela N, Adamczyk-Zostawa J, Wierzbicki K, Czuba Z, Zalejska-Fiolka J, Bartman W, Świętek A, Adamczyk-Sowa M. Lis M, et al. Biomedicines. 2024 Jul 17;12(7):1580. doi: 10.3390/biomedicines12071580. Biomedicines. 2024. PMID: 39062153 Free PMC article. - Nutritional interventional studies in patients with multiple sclerosis: a scoping review of the current clinical evidence.
Tryfonos C, Chrysafi M, Vadikolias K, Berberoglou L, Vorvolakos T, Dimoliani S, Tsourouflis G, Kontogiorgis C, Antasouras G, Giaginis C. Tryfonos C, et al. J Neurol. 2024 Apr;271(4):1536-1570. doi: 10.1007/s00415-023-12140-z. Epub 2024 Jan 4. J Neurol. 2024. PMID: 38177875 Review. - Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
Kujawa D, Laczmanski L, Budrewicz S, Pokryszko-Dragan A, Podbielska M. Kujawa D, et al. Gut Microbes. 2023 Dec;15(2):2274126. doi: 10.1080/19490976.2023.2274126. Epub 2023 Nov 18. Gut Microbes. 2023. PMID: 37979154 Free PMC article. Review.
References
- Neuroepidemiology. 2013;40(3):147-53 - PubMed
- Cytokine. 2010 May;50(2):175-80 - PubMed
- Lancet Neurol. 2015 Mar;14(3):263-73 - PubMed
- PLoS One. 2009 Aug 13;4(8):e6635 - PubMed
- Vasc Med. 2012 Dec;17(6):394-404 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical